Trials / Completed
CompletedNCT00956371
ONO-7746 Study in Healthy Adult Subjects
A Double-Blind, Placebo-Controlled, SIngle Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-7746 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to evaluate the safety and tolerability of ONO-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-7746 | 5mg, 10mg, 20mg, 50mg, 100mg, 200mg, 400mg, 800mg, 1200mg QD/1 day |
| DRUG | ONO-7746 | 5mg, 10mg, 20mg, 50mg, 100mg, 200mg, 400mg, 800mg, 1200mg QD/1 day |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-03-01
- First posted
- 2009-08-11
- Last updated
- 2012-06-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00956371. Inclusion in this directory is not an endorsement.